Lepu Medical Technology (Beijing) Co., Ltd. (300003.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 11.31

From 52W high−42.85%

Volume12.34M

Market capCNY 21.59B

P/E (TTM)22.4x

P/S (TTM)3.3x

Div yield2.84%

Key dataSep 18, 2026

Open

CNY 11.31

From 52W high

−42.85%

Volume

12.34M

Market cap

CNY 21.59B

ValuationView details →

P/E (Fwd)

25.0x

EV/EBITDA

12.3x

P/E (TTM)

22.4x

RSI (14)

40.5

MomentumView details →

1D Return

−3.78%

YTD Return

−27.58%

ValuationView details →

P/E (Fwd)

25.0x

P/E (TTM)

22.4x

EV/EBITDA

12.3x

EV/Sales

3.6x

P/S (TTM)

3.3x

P/B (TTM)

1.3x

ProfitabilityView details →

Gross Margin

63.49%

Net Margin

12.94%

EBITDA Margin

29.37%

ROE (TTM)

5.05%

ROA (TTM)

3.24%

Asset Turnover

0.25x

GrowthView details →

Revenue YoY

+8.47%

EPS YoY

+477.78%

FCF YoY

+67.42%

Revenue CAGR 3Y

−15.14%

EPS CAGR 3Y

−24.71%

EBITDA YoY

—

MomentumView details →

1D Return

−3.78%

YTD Return

−27.58%

1Y Return

−38.07%

RSI (14)

40.5

vs 50D SMA

−7.31%

vs 200D SMA

−22.73%

Capital & dividendView details →

Debt/Equity

0.26x

Current Ratio

2.38x

Quick Ratio

1.88x

Div Yield

2.84%

Div Rate

CNY 0.33

Div Growth 1Y

−37.11%

EarningsView details →

EPS (Actual)

CNY 0.13

EPS Surprise

−7.98%

Beats (12Q)

0/12

Next Q EPS Est

CNY 0.13

Avg Surprise (4Q)

−7.98%

Rev Surprise

−9.70%

Financials snapshotView financials →

Revenue (TTM)

6.42B

Net Income (TTM)

830.28M

Op. CF (TTM)

1.37B

Next earningsOct 23, 2026 →

Latest newsMore news →

Lifetech Scientific's subsidiary Shenzhen Jianxin Medical Technology and Fuwai Hospital received official notice from China's National Medical Products Administration that their Lantval aortic valve replacement system entered the special review procedure for innovative medical devices on September 9, 2026, marking the company's eighteenth product to enter this procedure.11d ago

Lifetech Scientific reported a net loss of RMB 34.348 million for the six months ended June 2026, compared with a net profit of RMB 55.074 million a year earlier, with revenue down 11.2% year-on-year to RMB 601 million.24d ago

Similar companies

万丰奥威002085.SZ 宏达电子300726.SZ 致尚科技301486.SZ 众生药业002317.SZ 航天发展000547.SZ 胜蓝股份300843.SZ Find similar companies →

Latest newsMore news →

Lifetech Scientific's subsidiary Shenzhen Jianxin Medical Technology and Fuwai Hospital received official notice from China's National Medical Products Administration that their Lantval aortic valve replacement system entered the special review procedure for innovative medical devices on September 9, 2026, marking the company's eighteenth product to enter this procedure.11d ago Lifetech Scientific reported a net loss of RMB 34.348 million for the six months ended June 2026, compared with a net profit of RMB 55.074 million a year earlier, with revenue down 11.2% year-on-year to RMB 601 million.24d ago